Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive StudyOriginal Paper Published on 2021-09-272022-10-29 Journal: Jmirx Med [Category] COVID-19, [키워드] 95% CI Admission Analysis antibody approach benefit Care Charlson Comorbidity Index Comorbidities Control control group covariate COVID-19 COVID-19 test Cox model demographics drug Efficacy eligible Establishing experience hazard ratio Health high risk Hospitalization Hospitalized immune therapy Immunotherapy In-hospital in-hospital mortality Infectious disease Mild Model Moderate COVID-19 monoclonal antibody monoclonal antibody therapy Mortality multivariable Neutralizing New York objective outcome pandemic Patient patient outcome positive COVID-19 presenting Primary outcome Probability receive reduce released Result retrospective cohort risk severe COVID-19 Sociodemographic study period survival symptom onset therapy to define Treatment vital signs was used Weighting [DOI] 10.2196/29638 PMC 바로가기 [Article Type] Original Paper
Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019Review Published on 2021-09-142023-06-15 Journal: Cytotherapy [Category] MERS, SARS, [키워드] immune therapy induced pluripotent stem cells Lung epithelial cells NK cells organoids SARS-CoV-2 T cells [DOI] 10.1016/j.jcyt.2021.08.003 PMC 바로가기 [Article Type] Review
Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?Immunology Published on 2021-08-172022-11-01 Journal: Frontiers in Immunology [Category] Coronavirus, MERS, SARS, [키워드] accelerate accelerated acute respiratory distress Adaptive immune response adaptive immune system anti-cancer response approved ARDS Autoimmune biological activity Bone marrow bone marrow failure Cancer Clinical data clinical setting clinical settings COVID-19 database Diseases drug Efficacy ENhance Essential example FDA GM-CSF granulocyte-macrophage colony-stimulating factor hematologic host immunity humans immune Immune checkpoint inhibitor immune modulation Immune suppression immune therapy Immunotherapy Infection infections innate immune response less modulating monoclonal antibodies objective Other Pulmonary alveolar proteinosis reported Result resulting review safety profile sargramostim Sepsis significantly solid cancer survival syndrome Therapies therapy tissue repair Toxicity trauma US FDA Vaccine variety [DOI] 10.3389/fimmu.2021.706186 PMC 바로가기 [Article Type] Immunology
Efficacy of Different Types of Therapy for COVID-19: A Comprehensive ReviewReview Published on 2021-07-272022-10-29 Journal: International Review of Cell and Molecular Biology [Category] COVID-19, [키워드] affected Analysis analyzed Antiviral antiviral drug antiviral therapy Clinical improvement Comprehensive conditions control groups Coronavirus infection COVID-19 Critical Cytokines Data analysis decrease Dexamethasone disease Efficacy immune immune therapy immunosuppressive intravenous immunoglobulin IgG Mortality mortality rate New coronavirus not differ Patient patients with COVID-19 plasma regimen review SARS-CoV-2 shown significantly Standard therapy target therapy treated Treatment Type viral life cycle [DOI] 10.3390/life11080753 PMC 바로가기 [Article Type] Review
Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis콜히친 치료는 코로나바이러스 질병 2019(COVID-19)의 결과를 개선할 수 있습니다: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-06-012022-09-11 Journal: Clinical and experimental pharmacology & physiolog [Category] SARS, 임상, [키워드] 95% CI administration Analysis article benefit clinical trial Colchicine colchicine treatment coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient COVID-19 patients database effective Efficacy eight Europe immune immune therapy IMPROVE Inflammation Inflammatory diseases Meta-analysis mortality rate Newcastle-Ottawa Scale NOS observational studies observational study offer outcome PMC randomized clinical trial randomized trial randomized trials reducing reduction retrieved review RoB 2 searched severe COVID-19 shown statistical analysis systematic review the Newcastle-Ottawa Scale Treatment was done [DOI] 10.1111/1440-1681.13488 PMC 바로가기 [Article Type] Meta-Analysis
Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung Diseases면역 치료 엑소좀의 단백질 특성, 생체 분포 및 기능 연구: 염증성 폐 질환에 대한 시사점Immunology Published on 2021-03-252022-09-11 Journal: Frontiers in Immunology [Category] SARS, 유전자 메커니즘, [키워드] ACE2 activated acute respiratory syndrome acute respiratory syndrome coronavirus addition analyzed binding biodistribution blocking bone disease Cell characterization circulation clinical trial clinical trials complex controls coronavirus COVID-19 DCs dendritic cell dendritic cells disease downregulate downstream Effect Efficacy Exosome Exosomes experiment expression followed by functions identify immature immune immune response immune therapy immunoblot Immunotherapy implication In-vitro Inflammatory Inflammatory diseases inflammatory disorders initial Interaction internalization Intravenous injection involved liver tissue lung Lung diseases Lungs major organ major organs mice parenchymal parenchymal cells peripheral tissues predominant presenting Protein Proteins proteomics respiratory scrutiny Signaling spleen suggested sustained target target proteins target receptor therapeutic therapy transmigration various inflammatory diseases [DOI] 10.3389/fimmu.2021.636222 PMC 바로가기 [Article Type] Immunology
Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and CancerReview Published on 2021-02-232024-09-02 Journal: Frontiers in immunology [Category] 대상포진, [키워드] Cancer immune therapy Infection Inflammation precision medicine [DOI] 10.3389/fimmu.2021.595722 PMC 바로가기 [Article Type] Review
Association of active oncologic treatment and risk of death in cancer patients with COVID-19: a systematic review and meta-analysis of patient dataMeta-Analysis Published on 2021-01-012023-07-12 Journal: Acta oncologica (Stockholm, Sweden) [Category] SARS, [키워드] Chemoimmunotherapy Chemotherapy COVID-19 immune therapy targeted therapy [DOI] 10.1080/0284186X.2020.1837946 [Article Type] Meta-Analysis
Moving Fast Toward Hepatitis B Virus EliminationArticle Published on 2021-01-012023-06-12 Journal: Advances in experimental medicine and biology [Category] B형 간염, [키워드] cccDNA core inhibitor DAA—directly acting antiviral hepatitis B Hepatocellular carcinoma immune therapy [DOI] 10.1007/978-981-16-0267-2_5 PMC 바로가기
Immuntherapien zur Behandlung der chronischen Hepatitis-B-Virusinfektion – eine Übersicht unter besonderer Berücksichtigung von CAR-T-ZellenArticle Published on 2020-09-292023-06-02 Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesu [Category] B형 간염, [키워드] CAR T cells CAR-T-Zellen checkpoint inhibitors Checkpointinhibitoren Hepatitis B virus Hepatitis-B-Virus immune therapy Immuntherapie Impfstoffe Vaccines [DOI] 10.1007/s00103-020-03223-7 PMC 바로가기